Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 483058.8 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 399944.75 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 486407.21 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 460256.57 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 398107.17 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 416869.38 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 323593.66 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 361409.86 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 483058.8 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 458141.89 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 468813.38 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 421696.5 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 496592.32 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 417830.37 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 416869.38 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 479733.45 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 462381.02 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 488652.36 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 488652.36 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 478630.09 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 358921.93 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 423642.97 | nM | PubChem BioAssay data set | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 353997.34 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 443608.64 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 495450.19 | nM | PubChem BioAssay data set | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 441570.45 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 417830.37 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 477529.27 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 463446.92 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 469894.11 | nM | PubChem BioAssay data set | |
NPT168 | Cell Line | P388 | Mus musculus | GI50 | 366437.57 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 496592.32 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 353183.17 | nM | PubChem BioAssay data set | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 337287.31 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 387257.64 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 483058.8 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 472063.04 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 440554.86 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 488652.36 | nM | PubChem BioAssay data set | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 466659.38 | nM | PubChem BioAssay data set | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 425598.41 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 258226.02 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 417830.37 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 414954.04 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 236591.97 | nM | PubChem BioAssay data set | |
NPT552 | Cell Line | P388/ADR | Mus musculus | GI50 | 291071.71 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 447713.3 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 449779.85 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 500034.53 | nM | PubChem BioAssay data set | |
NPT577 | Cell Line | RXF 631 | Homo sapiens | GI50 | 179887.09 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 407380.28 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 454988.06 | nM | PubChem BioAssay data set | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 483058.8 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 391741.88 | nM | PubChem BioAssay data set | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 494310.69 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 484172.37 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 385478.36 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 493173.8 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 484172.37 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 472063.04 | nM | PubChem BioAssay data set | |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | 227509.74 | nM | PubChem BioAssay data set | |
NPT738 | Cell Line | SN12K1 | Homo sapiens | GI50 | 404575.89 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC315642 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC74306 |
0.8741 | High Similarity | NPC262926 |
0.8676 | High Similarity | NPC61198 |
0.8456 | Intermediate Similarity | NPC324009 |
0.8417 | Intermediate Similarity | NPC30326 |
0.8394 | Intermediate Similarity | NPC319221 |
0.8369 | Intermediate Similarity | NPC186619 |
0.8322 | Intermediate Similarity | NPC317746 |
0.8264 | Intermediate Similarity | NPC64705 |
0.8264 | Intermediate Similarity | NPC232408 |
0.8252 | Intermediate Similarity | NPC211820 |
0.8252 | Intermediate Similarity | NPC251233 |
0.8252 | Intermediate Similarity | NPC318590 |
0.8194 | Intermediate Similarity | NPC177169 |
0.8194 | Intermediate Similarity | NPC89147 |
0.8194 | Intermediate Similarity | NPC274384 |
0.8143 | Intermediate Similarity | NPC320818 |
0.7704 | Intermediate Similarity | NPC327579 |
0.7703 | Intermediate Similarity | NPC107374 |
0.7703 | Intermediate Similarity | NPC21448 |
0.7703 | Intermediate Similarity | NPC156461 |
0.7651 | Intermediate Similarity | NPC164665 |
0.7651 | Intermediate Similarity | NPC189068 |
0.76 | Intermediate Similarity | NPC309832 |
0.76 | Intermediate Similarity | NPC269827 |
0.76 | Intermediate Similarity | NPC219313 |
0.7568 | Intermediate Similarity | NPC229974 |
0.7551 | Intermediate Similarity | NPC209525 |
0.7551 | Intermediate Similarity | NPC161659 |
0.7532 | Intermediate Similarity | NPC14590 |
0.75 | Intermediate Similarity | NPC239737 |
0.7468 | Intermediate Similarity | NPC321052 |
0.7451 | Intermediate Similarity | NPC326694 |
0.7451 | Intermediate Similarity | NPC150853 |
0.745 | Intermediate Similarity | NPC314152 |
0.7436 | Intermediate Similarity | NPC52238 |
0.7432 | Intermediate Similarity | NPC317821 |
0.7403 | Intermediate Similarity | NPC185991 |
0.7403 | Intermediate Similarity | NPC85689 |
0.7403 | Intermediate Similarity | NPC211025 |
0.7389 | Intermediate Similarity | NPC54320 |
0.7389 | Intermediate Similarity | NPC311197 |
0.7389 | Intermediate Similarity | NPC313754 |
0.7372 | Intermediate Similarity | NPC174802 |
0.7355 | Intermediate Similarity | NPC321814 |
0.7355 | Intermediate Similarity | NPC472816 |
0.732 | Intermediate Similarity | NPC121222 |
0.7308 | Intermediate Similarity | NPC130586 |
0.7308 | Intermediate Similarity | NPC212551 |
0.7308 | Intermediate Similarity | NPC164952 |
0.7308 | Intermediate Similarity | NPC302778 |
0.729 | Intermediate Similarity | NPC161224 |
0.7278 | Intermediate Similarity | NPC226245 |
0.7244 | Intermediate Similarity | NPC207633 |
0.7215 | Intermediate Similarity | NPC224076 |
0.7206 | Intermediate Similarity | NPC313547 |
0.717 | Intermediate Similarity | NPC316618 |
0.7134 | Intermediate Similarity | NPC328479 |
0.7073 | Intermediate Similarity | NPC261595 |
0.7055 | Intermediate Similarity | NPC323091 |
0.7051 | Intermediate Similarity | NPC136349 |
0.703 | Intermediate Similarity | NPC321458 |
0.703 | Intermediate Similarity | NPC324033 |
0.702 | Intermediate Similarity | NPC129756 |
0.7019 | Intermediate Similarity | NPC195140 |
0.6882 | Remote Similarity | NPC189261 |
0.6807 | Remote Similarity | NPC324484 |
0.6786 | Remote Similarity | NPC290959 |
0.6766 | Remote Similarity | NPC325906 |
0.6735 | Remote Similarity | NPC180462 |
0.6732 | Remote Similarity | NPC33996 |
0.6725 | Remote Similarity | NPC326529 |
0.6686 | Remote Similarity | NPC324198 |
0.6686 | Remote Similarity | NPC319100 |
0.6686 | Remote Similarity | NPC326082 |
0.6647 | Remote Similarity | NPC222174 |
0.6629 | Remote Similarity | NPC313514 |
0.6628 | Remote Similarity | NPC313897 |
0.6581 | Remote Similarity | NPC210947 |
0.6545 | Remote Similarity | NPC93365 |
0.6529 | Remote Similarity | NPC168702 |
0.6529 | Remote Similarity | NPC125659 |
0.6524 | Remote Similarity | NPC60537 |
0.6471 | Remote Similarity | NPC33382 |
0.6444 | Remote Similarity | NPC293163 |
0.6375 | Remote Similarity | NPC174020 |
0.6369 | Remote Similarity | NPC470139 |
0.6364 | Remote Similarity | NPC327613 |
0.6335 | Remote Similarity | NPC327477 |
0.6329 | Remote Similarity | NPC286696 |
0.6329 | Remote Similarity | NPC185903 |
0.6323 | Remote Similarity | NPC126634 |
0.6304 | Remote Similarity | NPC59314 |
0.6282 | Remote Similarity | NPC470140 |
0.6214 | Remote Similarity | NPC119133 |
0.62 | Remote Similarity | NPC250178 |
0.6188 | Remote Similarity | NPC24589 |
0.6181 | Remote Similarity | NPC41958 |
0.6175 | Remote Similarity | NPC282458 |
0.6175 | Remote Similarity | NPC78941 |
0.6139 | Remote Similarity | NPC18223 |
0.6139 | Remote Similarity | NPC470141 |
0.6139 | Remote Similarity | NPC237812 |
0.6062 | Remote Similarity | NPC103388 |
0.6047 | Remote Similarity | NPC321393 |
0.6026 | Remote Similarity | NPC470138 |
0.6026 | Remote Similarity | NPC235501 |
0.599 | Remote Similarity | NPC107160 |
0.5986 | Remote Similarity | NPC63433 |
0.5981 | Remote Similarity | NPC21461 |
0.5957 | Remote Similarity | NPC10466 |
0.5957 | Remote Similarity | NPC201900 |
0.5929 | Remote Similarity | NPC326248 |
0.5929 | Remote Similarity | NPC187191 |
0.5924 | Remote Similarity | NPC25465 |
0.5897 | Remote Similarity | NPC157821 |
0.5887 | Remote Similarity | NPC273327 |
0.5876 | Remote Similarity | NPC276373 |
0.5873 | Remote Similarity | NPC313504 |
0.5855 | Remote Similarity | NPC470142 |
0.5846 | Remote Similarity | NPC5802 |
0.5829 | Remote Similarity | NPC160666 |
0.5779 | Remote Similarity | NPC109322 |
0.5764 | Remote Similarity | NPC155498 |
0.5758 | Remote Similarity | NPC8590 |
0.5742 | Remote Similarity | NPC15566 |
0.5734 | Remote Similarity | NPC111132 |
0.5714 | Remote Similarity | NPC320256 |
0.5687 | Remote Similarity | NPC57279 |
0.5602 | Remote Similarity | NPC158055 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC315642 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD582 | Approved |
0.8864 | High Similarity | NPD9632 | Phase 3 |
0.8676 | High Similarity | NPD252 | Clinical (unspecified phase) |
0.8467 | Intermediate Similarity | NPD194 | Clinical (unspecified phase) |
0.8298 | Intermediate Similarity | NPD549 | Approved |
0.7987 | Intermediate Similarity | NPD3086 | Phase 3 |
0.7919 | Intermediate Similarity | NPD3085 | Phase 1 |
0.7815 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.7727 | Intermediate Similarity | NPD2624 | Phase 2 |
0.7704 | Intermediate Similarity | NPD9607 | Approved |
0.7703 | Intermediate Similarity | NPD249 | Approved |
0.7703 | Intermediate Similarity | NPD250 | Approved |
0.7677 | Intermediate Similarity | NPD4074 | Clinical (unspecified phase) |
0.7647 | Intermediate Similarity | NPD1750 | Clinical (unspecified phase) |
0.7647 | Intermediate Similarity | NPD1369 | Phase 2 |
0.763 | Intermediate Similarity | NPD9606 | Approved |
0.7622 | Intermediate Similarity | NPD209 | Clinical (unspecified phase) |
0.76 | Intermediate Similarity | NPD195 | Approved |
0.76 | Intermediate Similarity | NPD186 | Discovery |
0.75 | Intermediate Similarity | NPD2646 | Discontinued |
0.75 | Intermediate Similarity | NPD1732 | Phase 3 |
0.745 | Intermediate Similarity | NPD185 | Approved |
0.7419 | Intermediate Similarity | NPD3107 | Discontinued |
0.7407 | Intermediate Similarity | NPD9374 | Approved |
0.7403 | Intermediate Similarity | NPD283 | Approved |
0.7389 | Intermediate Similarity | NPD217 | Approved |
0.7389 | Intermediate Similarity | NPD219 | Phase 3 |
0.7389 | Intermediate Similarity | NPD218 | Approved |
0.7389 | Intermediate Similarity | NPD220 | Clinical (unspecified phase) |
0.7389 | Intermediate Similarity | NPD216 | Approved |
0.7372 | Intermediate Similarity | NPD339 | Approved |
0.7351 | Intermediate Similarity | NPD166 | Approved |
0.7319 | Intermediate Similarity | NPD307 | Approved |
0.7315 | Intermediate Similarity | NPD193 | Suspended |
0.731 | Intermediate Similarity | NPD545 | Clinical (unspecified phase) |
0.7308 | Intermediate Similarity | NPD214 | Approved |
0.7308 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.7308 | Intermediate Similarity | NPD242 | Approved |
0.7308 | Intermediate Similarity | NPD338 | Approved |
0.729 | Intermediate Similarity | NPD353 | Discontinued |
0.7267 | Intermediate Similarity | NPD1431 | Approved |
0.7267 | Intermediate Similarity | NPD1430 | Approved |
0.7259 | Intermediate Similarity | NPD9373 | Approved |
0.7215 | Intermediate Similarity | NPD169 | Phase 2 |
0.7208 | Intermediate Similarity | NPD775 | Approved |
0.7192 | Intermediate Similarity | NPD547 | Clinical (unspecified phase) |
0.7134 | Intermediate Similarity | NPD9605 | Phase 3 |
0.7073 | Intermediate Similarity | NPD247 | Clinical (unspecified phase) |
0.7069 | Intermediate Similarity | NPD2152 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD548 | Clinical (unspecified phase) |
0.703 | Intermediate Similarity | NPD2647 | Phase 3 |
0.6959 | Remote Similarity | NPD4716 | Approved |
0.6954 | Remote Similarity | NPD1808 | Phase 1 |
0.6933 | Remote Similarity | NPD1120 | Approved |
0.6933 | Remote Similarity | NPD1121 | Approved |
0.6923 | Remote Similarity | NPD5666 | Phase 2 |
0.6919 | Remote Similarity | NPD4744 | Clinical (unspecified phase) |
0.6901 | Remote Similarity | NPD9409 | Discontinued |
0.6849 | Remote Similarity | NPD515 | Phase 1 |
0.6812 | Remote Similarity | NPD9375 | Discontinued |
0.6766 | Remote Similarity | NPD7988 | Suspended |
0.6766 | Remote Similarity | NPD1777 | Approved |
0.6766 | Remote Similarity | NPD1776 | Approved |
0.6743 | Remote Similarity | NPD1692 | Approved |
0.6689 | Remote Similarity | NPD870 | Clinical (unspecified phase) |
0.6687 | Remote Similarity | NPD5768 | Phase 2 |
0.6686 | Remote Similarity | NPD4171 | Clinical (unspecified phase) |
0.6647 | Remote Similarity | NPD1412 | Clinical (unspecified phase) |
0.6629 | Remote Similarity | NPD7138 | Phase 2 |
0.6627 | Remote Similarity | NPD516 | Clinical (unspecified phase) |
0.6618 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.66 | Remote Similarity | NPD248 | Discontinued |
0.6587 | Remote Similarity | NPD3083 | Approved |
0.6573 | Remote Similarity | NPD5682 | Phase 3 |
0.6573 | Remote Similarity | NPD5683 | Clinical (unspecified phase) |
0.6573 | Remote Similarity | NPD6417 | Clinical (unspecified phase) |
0.6573 | Remote Similarity | NPD5684 | Clinical (unspecified phase) |
0.6545 | Remote Similarity | NPD546 | Clinical (unspecified phase) |
0.6545 | Remote Similarity | NPD3697 | Discontinued |
0.6543 | Remote Similarity | NPD7842 | Phase 2 |
0.6528 | Remote Similarity | NPD9360 | Approved |
0.6524 | Remote Similarity | NPD2180 | Approved |
0.6508 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.6508 | Remote Similarity | NPD2876 | Phase 3 |
0.65 | Remote Similarity | NPD2631 | Clinical (unspecified phase) |
0.65 | Remote Similarity | NPD2632 | Approved |
0.65 | Remote Similarity | NPD2630 | Approved |
0.6463 | Remote Similarity | NPD1731 | Clinical (unspecified phase) |
0.644 | Remote Similarity | NPD2824 | Phase 2 |
0.6434 | Remote Similarity | NPD9584 | Phase 2 |
0.6419 | Remote Similarity | NPD798 | Discontinued |
0.6368 | Remote Similarity | NPD2965 | Clinical (unspecified phase) |
0.6352 | Remote Similarity | NPD1451 | Approved |
0.6347 | Remote Similarity | NPD2604 | Approved |
0.6323 | Remote Similarity | NPD1119 | Phase 2 |
0.6312 | Remote Similarity | NPD5342 | Clinical (unspecified phase) |
0.6304 | Remote Similarity | NPD8837 | Clinical (unspecified phase) |
0.6301 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.6296 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.6294 | Remote Similarity | NPD3130 | Discontinued |
0.6286 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.6241 | Remote Similarity | NPD9416 | Phase 3 |
0.6241 | Remote Similarity | NPD9417 | Phase 3 |
0.6236 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.6234 | Remote Similarity | NPD282 | Approved |
0.6214 | Remote Similarity | NPD9291 | Approved |
0.6196 | Remote Similarity | NPD4054 | Clinical (unspecified phase) |
0.6188 | Remote Similarity | NPD2253 | Discontinued |
0.6184 | Remote Similarity | NPD300 | Approved |
0.6182 | Remote Similarity | NPD3708 | Phase 2 |
0.6139 | Remote Similarity | NPD9628 | Approved |
0.6139 | Remote Similarity | NPD9133 | Approved |
0.6139 | Remote Similarity | NPD6381 | Phase 2 |
0.6125 | Remote Similarity | NPD875 | Clinical (unspecified phase) |
0.6105 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.6074 | Remote Similarity | NPD7158 | Phase 1 |
0.6069 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.6041 | Remote Similarity | NPD4495 | Phase 1 |
0.6039 | Remote Similarity | NPD1355 | Clinical (unspecified phase) |
0.6039 | Remote Similarity | NPD1127 | Approved |
0.6039 | Remote Similarity | NPD1356 | Approved |
0.6039 | Remote Similarity | NPD1128 | Approved |
0.6039 | Remote Similarity | NPD1354 | Approved |
0.6033 | Remote Similarity | NPD1063 | Phase 2 |
0.6025 | Remote Similarity | NPD1118 | Discontinued |
0.6014 | Remote Similarity | NPD1368 | Approved |
0.6012 | Remote Similarity | NPD231 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD9633 | Phase 3 |
0.5986 | Remote Similarity | NPD9406 | Approved |
0.5976 | Remote Similarity | NPD9627 | Approved |
0.5955 | Remote Similarity | NPD3105 | Discontinued |
0.5951 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.5951 | Remote Similarity | NPD6036 | Suspended |
0.5951 | Remote Similarity | NPD9183 | Clinical (unspecified phase) |
0.5915 | Remote Similarity | NPD566 | Approved |
0.5915 | Remote Similarity | NPD567 | Approved |
0.5915 | Remote Similarity | NPD568 | Approved |
0.5909 | Remote Similarity | NPD9408 | Phase 3 |
0.5909 | Remote Similarity | NPD281 | Approved |
0.5907 | Remote Similarity | NPD4599 | Clinical (unspecified phase) |
0.59 | Remote Similarity | NPD2902 | Phase 2 |
0.59 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.5876 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.5876 | Remote Similarity | NPD4458 | Phase 2 |
0.5843 | Remote Similarity | NPD1730 | Discontinued |
0.5823 | Remote Similarity | NPD9650 | Phase 3 |
0.5808 | Remote Similarity | NPD796 | Phase 2 |
0.5801 | Remote Similarity | NPD3108 | Clinical (unspecified phase) |
0.5776 | Remote Similarity | NPD535 | Approved |
0.5751 | Remote Similarity | NPD691 | Discontinued |
0.5734 | Remote Similarity | NPD8862 | Approved |
0.5734 | Remote Similarity | NPD8859 | Approved |
0.5734 | Remote Similarity | NPD8861 | Approved |
0.5707 | Remote Similarity | NPD5080 | Phase 2 |
0.5659 | Remote Similarity | NPD5079 | Phase 2 |
0.5655 | Remote Similarity | NPD9196 | Phase 2 |
0.5655 | Remote Similarity | NPD9415 | Clinical (unspecified phase) |
0.5652 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.5652 | Remote Similarity | NPD4555 | Clinical (unspecified phase) |
0.5646 | Remote Similarity | NPD613 | Phase 2 |
0.5636 | Remote Similarity | NPD3695 | Approved |
0.5636 | Remote Similarity | NPD3696 | Approved |
0.5632 | Remote Similarity | NPD207 | Discontinued |
0.5625 | Remote Similarity | NPD245 | Suspended |
0.5602 | Remote Similarity | NPD6840 | Approved |
PubChem CID   | 40926 |
ChEMBL   | CHEMBL360191 |
ZINC   |
Molecular Weight:   | 268.12 |
ALogP:   | -2.5753 |
MLogP:   | 1.79 |
XLogP:   | -1.481 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 112.13 |
# H-Bond Aceptor:   | 8 |
# H-Bond Donor:   | 4 |
# Rings:   | 3 |
# Heavy Atoms:   | 19 |